Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer - Top-Institutions - MDSpire

Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

  • By

  • Wolfgang Lilleby

  • Amar Kishan

  • Hans Geinitz

  • January 20, 2024

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Clinical Trials

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiation Oncology
    • Urology
    • Cancer Survivorship

  • #3

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Radiation Oncology
    • Medical Oncology
    • Clinical Research

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Patient-Reported Outcomes

  • #5

    University of Michigan Rogel Cancer Center
    University of Michigan Rogel Cancer Center

    Ann Arbor, MI

    Key Differentiators

    • Radiation Oncology
    • Clinical Trials
    • Prostate Cancer

Original Source(s)

Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

  • by Wolfgang Lilleby, Amar Kishan, Hans Geinitz

  • January 20, 2024

Related Content

Evaluation of Radiation Therapy Protocols Before and After Biodegradable Hydrogel (SpaceOAR) Administration to Mitigate Rectal Toxicity in Prostate Cancer Patients Receiving Carbon Ion Radiotherapy

Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review

Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy